nocodazole has been researched along with sirolimus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Dumont, FJ; Fischer, P; Sirotina, A | 1 |
| Beamish, H; Chen, P; Hobson, K; Khanna, KK; Lavin, M; Shiloh, Y; Watters, D; Williams, R | 1 |
| Dupuis, G; Martel, J; Payet, MD | 1 |
| Bevilacqua, A; Calastretti, A; Capaccioli, S; Ceriani, C; Nicolin, A; Viganò, S; Zancai, P | 1 |
| Backer, JM; Brachmann, SM; Cooper, J; Eskelinen, EL; Lucocq, JM; Prescott, AR; Tang, X; Wang, L | 1 |
| Asnaghi, L; Bevilacqua, A; Calastretti, A; Canti, G; Capaccioli, S; D'Agnano, I; Delia, D; Gatti, G; Nicolin, A | 1 |
| Malhotra, V; Pecot, MY | 1 |
| Colombo, MI; Fader, CM; Furlán, M; Sánchez, D | 1 |
| Cao, J; Chen, W; Dai, B; Lin, D; Liu, L; Liu, Y; Ma, D; Sun, Y; Yu, H | 1 |
| Apontes, P; Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Li, F | 1 |
| Blagosklonny, MV | 1 |
| Blagosklonny, MV; Demidenko, ZN; Gudkov, AV; Leontieva, OV | 1 |
| Corominas-Faja, B; Cufí, S; López-Bonet, E; Menendez, JA; Menendez, OJ; Oliveras-Ferraros, C; Sauri-Nadal, T; Vazquez-Martin, A | 1 |
| Aravamudhan, P; Goldfarb, AA; Joglekar, AP | 1 |
| Bílý, T; Elsterová, J; Eyer, L; Palus, M; Růžek, D; Vancová, M | 1 |
| Bosch, A; Casas, C; Forés, J; Herrando-Grabulosa, M; Leiva-Rodríguez, T; Marmolejo-Martínez-Artesero, S; Romeo-Guitart, D | 1 |
1 review(s) available for nocodazole and sirolimus
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
16 other study(ies) available for nocodazole and sirolimus
| Article | Year |
|---|---|
Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
Topics: Animals; Antibodies; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cell Cycle; Cell Division; Cell Line; Culture Media, Serum-Free; Flow Cytometry; G1 Phase; Hydroxyurea; Immunosuppressive Agents; Lymphocyte Function-Associated Antigen-1; Lymphoma, T-Cell; Mimosine; Nocodazole; Polyenes; Sirolimus; Tacrolimus; Tumor Cells, Cultured | 1995 |
Rapamycin resistance in ataxia-telangiectasia.
Topics: Amino Acid Sequence; Androstadienes; Antibiotics, Antineoplastic; Antifungal Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Binding Sites; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Heat-Shock Proteins; Humans; Immunosuppressive Agents; Molecular Sequence Data; Mutation; Nocodazole; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Polyenes; Protein Serine-Threonine Kinases; Proteins; Recombinant Fusion Proteins; Ribosomal Protein S6 Kinases; Sirolimus; Tacrolimus Binding Proteins; Tumor Cells, Cultured; Tumor Suppressor Proteins; Wortmannin | 1996 |
The MRD1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes.
Topics: Antineoplastic Agents; Aphidicolin; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; CD4-Positive T-Lymphocytes; Cell Cycle; Colchicine; Cyclosporine; Drug Resistance, Multiple; Humans; Jurkat Cells; Multidrug Resistance-Associated Proteins; Nocodazole; Polyenes; Sirolimus | 1997 |
Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase.
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Diploidy; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Flow Cytometry; Humans; Microtubules; Nocodazole; Paclitaxel; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |
Inhibition of autophagy in mitotic animal cells.
Topics: Adenine; Anaphase; Androstadienes; Animals; Autophagy; Blotting, Western; Cell Line; Chromones; Endoplasmic Reticulum; Enzyme Inhibitors; Golgi Apparatus; HeLa Cells; Humans; Immunohistochemistry; Metaphase; Microscopy, Immunoelectron; Microscopy, Phase-Contrast; Mitosis; Morpholines; Nocodazole; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinases; Rats; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Telophase; Time Factors; TOR Serine-Threonine Kinases; Wortmannin | 2002 |
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.
Topics: Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; G2 Phase; Microtubules; Mitosis; Mutation; Nocodazole; Paclitaxel; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Ribosomal Protein S6 Kinases, 70-kDa; Serine; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2004 |
The Golgi apparatus maintains its organization independent of the endoplasmic reticulum.
Topics: Animals; Brefeldin A; Endoplasmic Reticulum; Golgi Apparatus; HeLa Cells; Humans; Intracellular Membranes; Mannose-Binding Lectins; Membrane Proteins; Mice; Nocodazole; Protein Kinases; Sirolimus; Tacrolimus Binding Proteins; TOR Serine-Threonine Kinases; Transfection | 2006 |
Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells.
Topics: Amino Acids; Autophagy; Autophagy-Related Protein 12; Cadaverine; Calcium; Chelating Agents; Culture Media, Serum-Free; Cytoplasmic Vesicles; Egtazic Acid; Exocytosis; HSC70 Heat-Shock Proteins; Humans; K562 Cells; Membrane Fusion; Microtubule-Associated Proteins; Models, Biological; Monensin; Nocodazole; Proteins; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins; Recombinant Fusion Proteins; RNA, Small Interfering; Sirolimus; Small Ubiquitin-Related Modifier Proteins; Transfection; Vinblastine | 2008 |
S6K1 is involved in polyploidization through its phosphorylation at Thr421/Ser424.
Topics: Adaptor Proteins, Signal Transducing; Androstadienes; Animals; Antineoplastic Agents; Carcinogens; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Chromones; Cyclin B; Enzyme Inhibitors; Humans; Megakaryocytes; Morpholines; Nocodazole; Phosphoproteins; Phosphorylation; Polyploidy; Protein Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Serine; Sirolimus; Tetradecanoylphorbol Acetate; Threonine; TOR Serine-Threonine Kinases; Wortmannin | 2009 |
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytoprotection; Epithelial Cells; Fibroblasts; G1 Phase; Humans; Imidazoles; Metformin; Nocodazole; Paclitaxel; Piperazines; Sirolimus; Tumor Suppressor Protein p53 | 2011 |
The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Humans; Imidazoles; Isopropyl Thiogalactoside; Mitosis; Nocodazole; Piperazines; Sirolimus; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2011 |
Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Shape; Cellular Senescence; Humans; Imidazoles; Isopropyl Thiogalactoside; Nocodazole; Piperazines; Sirolimus | 2011 |
Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis.
Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Cell Division; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Chromosomes; Cytokinesis; HeLa Cells; Humans; MCF-7 Cells; Microtubules; Nocodazole; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Sirolimus; Telophase; TOR Serine-Threonine Kinases | 2012 |
The kinetochore encodes a mechanical switch to disrupt spindle assembly checkpoint signalling.
Topics: Aurora Kinases; Cell Cycle Checkpoints; Cell Cycle Proteins; Kinetochores; Luminescent Proteins; Microscopy, Fluorescence; Microtubule-Associated Proteins; Microtubules; Nocodazole; Nuclear Proteins; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Sirolimus; Spindle Apparatus; Time-Lapse Imaging; Tubulin Modulators | 2015 |
Electron Tomography Analysis of Tick-Borne Encephalitis Virus Infection in Human Neurons.
Topics: Animals; Autophagy; Benzylamines; Cell Line, Tumor; Electron Microscope Tomography; Encephalitis Viruses, Tick-Borne; Endoplasmic Reticulum; Humans; Microtubules; Neurons; Nocodazole; Primary Cell Culture; Quinazolines; Sirolimus; Virion; Virus Replication | 2015 |
ATG5 overexpression is neuroprotective and attenuates cytoskeletal and vesicle-trafficking alterations in axotomized motoneurons.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 5; Axotomy; Cell Line; Cytoskeleton; Female; Glycosylation; Lysosomes; Microtubules; Models, Biological; Motor Neurons; Neuroprotection; Nocodazole; Protein Transport; Radiculopathy; Rats, Sprague-Dawley; Sirolimus; Synaptic Vesicles | 2018 |